CUTERA INC (CUTR)
US2321091082 - Common Stock
We assign a fundamental rating of 1 out of 10 to CUTR. CUTR was compared to 187 industry peers in the Health Care Equipment & Supplies industry. CUTR may be in some trouble as it scores bad on both profitability and health. CUTR does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year CUTR has reported negative net income.
In the past year CUTR has reported a negative cash flow from operations.
CUTR had negative earnings in 4 of the past 5 years.
In the past 5 years CUTR reported 4 times negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -61.31%, CUTR is not doing good in the industry: 72.58% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -61.31% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-20.69%
ROA(5y)-18.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 5.93%, CUTR is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CUTR has declined.
CUTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 5.93% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.52%
GM growth 5Y-16.94%
2. Health
2.1 Basic Checks
CUTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CUTR has more shares outstanding
CUTR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CUTR has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -3.15, we must say that CUTR is in the distress zone and has some risk of bankruptcy.
CUTR's Altman-Z score of -3.15 is on the low side compared to the rest of the industry. CUTR is outperformed by 67.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.15 |
ROIC/WACCN/A
WACC2.52%
2.3 Liquidity
A Current Ratio of 2.88 indicates that CUTR has no problem at all paying its short term obligations.
CUTR has a Current ratio of 2.88. This is comparable to the rest of the industry: CUTR outperforms 53.23% of its industry peers.
A Quick Ratio of 1.86 indicates that CUTR should not have too much problems paying its short term obligations.
The Quick ratio of CUTR (1.86) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.88 | ||
| Quick Ratio | 1.86 |
3. Growth
3.1 Past
CUTR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.75%.
CUTR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.53%.
CUTR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.47% yearly.
EPS 1Y (TTM)-53.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.73%
Revenue 1Y (TTM)-32.53%
Revenue growth 3Y12.87%
Revenue growth 5Y5.47%
Sales Q2Q%-30.07%
3.2 Future
Based on estimates for the next years, CUTR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.52% on average per year.
Based on estimates for the next years, CUTR will show a small growth in Revenue. The Revenue will grow by 4.29% on average per year.
EPS Next Y-15.64%
EPS Next 2Y12.13%
EPS Next 3Y12.16%
EPS Next 5Y10.52%
Revenue Next Year-32.88%
Revenue Next 2Y-16.2%
Revenue Next 3Y-7.65%
Revenue Next 5Y4.29%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CUTR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CUTR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as CUTR's earnings are expected to grow with 12.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.13%
EPS Next 3Y12.16%
5. Dividend
5.1 Amount
CUTR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CUTERA INC
NASDAQ:CUTR (1/3/2025, 8:00:01 PM)
After market: 0.5 +0.02 (+3.31%)0.484
+0.09 (+24.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners57.24%
Inst Owner Change-35.49%
Ins Owners0.64%
Ins Owner Change-1%
Market Cap9.77M
Analysts80
Price Target2.04 (321.49%)
Short Float %20.64%
Short Ratio11.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-46.13%
Min EPS beat(2)-70.55%
Max EPS beat(2)-21.7%
EPS beat(4)1
Avg EPS beat(4)-25.35%
Min EPS beat(4)-70.55%
Max EPS beat(4)31.14%
EPS beat(8)2
Avg EPS beat(8)-27.63%
EPS beat(12)3
Avg EPS beat(12)-73.2%
EPS beat(16)7
Avg EPS beat(16)33.41%
Revenue beat(2)0
Avg Revenue beat(2)-6.8%
Min Revenue beat(2)-12.9%
Max Revenue beat(2)-0.69%
Revenue beat(4)2
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-12.9%
Max Revenue beat(4)2.25%
Revenue beat(8)2
Avg Revenue beat(8)-4.68%
Revenue beat(12)3
Avg Revenue beat(12)-2.87%
Revenue beat(16)7
Avg Revenue beat(16)1.32%
PT rev (1m)33.33%
PT rev (3m)33.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.77%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-23.04%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.06 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-4.92
EYN/A
EPS(NY)-3.3
Fwd EYN/A
FCF(TTM)-5.96
FCFYN/A
OCF(TTM)-5.78
OCFYN/A
SpS7.69
BVpS-12.52
TBVpS-12.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -61.31% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 5.93% | ||
| FCFM | N/A |
ROA(3y)-20.69%
ROA(5y)-18.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.52%
GM growth 5Y-16.94%
F-Score2
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 42.64% | ||
| Cap/Sales | 2.42% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.88 | ||
| Quick Ratio | 1.86 | ||
| Altman-Z | -3.15 |
F-Score2
WACC2.52%
ROIC/WACCN/A
Cap/Depr(3y)442.5%
Cap/Depr(5y)296.69%
Cap/Sales(3y)8.33%
Cap/Sales(5y)5.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.73%
EPS Next Y-15.64%
EPS Next 2Y12.13%
EPS Next 3Y12.16%
EPS Next 5Y10.52%
Revenue 1Y (TTM)-32.53%
Revenue growth 3Y12.87%
Revenue growth 5Y5.47%
Sales Q2Q%-30.07%
Revenue Next Year-32.88%
Revenue Next 2Y-16.2%
Revenue Next 3Y-7.65%
Revenue Next 5Y4.29%
EBIT growth 1Y-45.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14.52%
EBIT Next 3Y16.97%
EBIT Next 5Y15.93%
FCF growth 1Y-94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-146.55%
OCF growth 3YN/A
OCF growth 5YN/A